Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NADH quinone oxidoreductase is a key enzyme involved in cellular respiration and redox biology. It catalyzes the transfer of electrons from NADH (or sometimes NADPH) to quinones, which are then reduced to hydroquinones. This process is essential for energy production, detoxification, and protection against oxidative stress in various organisms. There are two main types: Type I (NDH-1/Complex I), a large multi-subunit complex found in the mitochondrial inner membrane of eukaryotes and plasma membranes of bacteria, and Type II (NDH-2), a simpler, single-subunit enzyme present in many prokaryotes, plants, fungi, and some lower eukaryotes but absent from mammalian mitochondria.
Inhibition of electron transfer; Reduction of quinones to hydroquinones
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NADH Quinone Oxidoreductase (None).